SG11201510552WA - Therapy and method for intratumorally introducing cytotoxic t lymphocyte and/or nkt cell with anti-tnf and/or anti-il-10 - Google Patents
Therapy and method for intratumorally introducing cytotoxic t lymphocyte and/or nkt cell with anti-tnf and/or anti-il-10Info
- Publication number
- SG11201510552WA SG11201510552WA SG11201510552WA SG11201510552WA SG11201510552WA SG 11201510552W A SG11201510552W A SG 11201510552WA SG 11201510552W A SG11201510552W A SG 11201510552WA SG 11201510552W A SG11201510552W A SG 11201510552WA SG 11201510552W A SG11201510552W A SG 11201510552WA
- Authority
- SG
- Singapore
- Prior art keywords
- lymphocyte
- tnf
- therapy
- nkt cell
- intratumorally
- Prior art date
Links
- 210000004027 cell Anatomy 0.000 title 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C12N5/0638—Cytotoxic T lymphocytes [CTL] or lymphokine activated killer cells [LAK]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/47—Brain; Nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/49—Breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/55—Lung
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/58—Prostate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261664998P | 2012-06-27 | 2012-06-27 | |
PCT/US2013/048152 WO2014004809A2 (fr) | 2012-06-27 | 2013-06-27 | Thérapie et procédé pour l'introduction intra-tumorale d'un lymphocyte t cytotoxique et/ou d'une cellule nkt avec un anti-tnf et/ou anti-il-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201510552WA true SG11201510552WA (en) | 2016-01-28 |
Family
ID=49778407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201510552WA SG11201510552WA (en) | 2012-06-27 | 2013-06-27 | Therapy and method for intratumorally introducing cytotoxic t lymphocyte and/or nkt cell with anti-tnf and/or anti-il-10 |
Country Status (7)
Country | Link |
---|---|
US (1) | US8961957B2 (fr) |
EP (1) | EP3033417B1 (fr) |
GB (1) | GB2534478A (fr) |
HK (1) | HK1226099A1 (fr) |
RU (1) | RU2678083C2 (fr) |
SG (1) | SG11201510552WA (fr) |
WO (1) | WO2014004809A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9907819B2 (en) | 2012-06-27 | 2018-03-06 | Kenichiro Hasumi | Therapy and methods of introducing immature dendritic cells and/or cytotoxic T lymphocyte and anti-TNF antibody for treatment of tumors |
WO2015077532A1 (fr) * | 2013-11-21 | 2015-05-28 | Hasumi International Research Foundation | Thérapie et méthodes d'introduction de cellules dendritiques immatures et/ou de lymphocytes t cytotoxiques et anticorps anti-tnf pour traiter les tumeurs |
CN115645515A (zh) * | 2022-12-28 | 2023-01-31 | 北京圣美细胞生命科学工程研究院有限公司 | 肿瘤治疗组合物及应用、药物组合物和细胞生长抑制方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010026937A1 (en) * | 2000-01-11 | 2001-10-04 | Juha Punnonen | Monocyte-derived dendritic cell subsets |
TW200303759A (en) * | 2001-11-27 | 2003-09-16 | Schering Corp | Methods for treating cancer |
AT412145B (de) * | 2002-09-13 | 2004-10-25 | Forsch Krebskranke Kinder | Verfahren zur herstellung eines zellulären immuntherapeutikums auf basis von il-12-freisetzenden dendritischen zellen |
DK1567155T3 (da) | 2002-12-06 | 2011-02-14 | Northwest Biotherapeutics Inc | Administration of dendritiske celler, der er delvist modnet in vitro til behandlingen af tumorer |
EP1705992A1 (fr) * | 2004-01-20 | 2006-10-04 | Cedars-Sinai Medical Center | Distribution intratumorale de cellules dendritiques |
EP1712241A1 (fr) * | 2005-04-15 | 2006-10-18 | Centre National De La Recherche Scientifique (Cnrs) | Composition pour application intratumorale dans le traitement du cancer |
JP2010508364A (ja) * | 2006-10-31 | 2010-03-18 | ハスミ インターナショナル リサーチ ファウンデイション | 樹状細胞腫瘍注射治療及び関連するワクチン |
US20080160050A1 (en) * | 2006-10-31 | 2008-07-03 | Kenichiro Hasumi | Dendritic cell tumor injection therapy and related vaccine |
JP2010522772A (ja) * | 2007-03-28 | 2010-07-08 | バイオジェン・アイデック・インコーポレイテッド | 腫瘍微小環境の調整 |
US8666674B2 (en) * | 2009-07-28 | 2014-03-04 | Promising Future, Llc | Pairing processes for preparing reactive cytotoxic T cells |
-
2013
- 2013-06-27 RU RU2016102172A patent/RU2678083C2/ru active
- 2013-06-27 WO PCT/US2013/048152 patent/WO2014004809A2/fr active Application Filing
- 2013-06-27 GB GB1601559.6A patent/GB2534478A/en not_active Withdrawn
- 2013-06-27 SG SG11201510552WA patent/SG11201510552WA/en unknown
- 2013-06-27 EP EP13809052.7A patent/EP3033417B1/fr active Active
- 2013-06-27 US US13/928,844 patent/US8961957B2/en active Active
-
2016
- 2016-12-21 HK HK16114524A patent/HK1226099A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US8961957B2 (en) | 2015-02-24 |
GB2534478A (en) | 2016-07-27 |
GB201601559D0 (en) | 2016-03-16 |
RU2016102172A (ru) | 2017-07-28 |
HK1226099A1 (zh) | 2017-09-22 |
WO2014004809A3 (fr) | 2014-02-20 |
RU2678083C2 (ru) | 2019-01-23 |
EP3033417A4 (fr) | 2017-06-14 |
EP3033417A2 (fr) | 2016-06-22 |
EP3033417B1 (fr) | 2019-12-25 |
WO2014004809A2 (fr) | 2014-01-03 |
US20140004126A1 (en) | 2014-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1222204A1 (zh) | 用於轉染細胞的方法和產品 | |
IL238205A0 (en) | Oxygen center systems and methods | |
ZA201502884B (en) | Compositions and methods for modulating cell signaling | |
EP2881138A4 (fr) | Ensemble de perfusion et procédé pour utiliser celui-ci | |
EP2689614A4 (fr) | Procédé et appareil conçus pour une batterie comportant un élément sécurisé | |
IL238203A0 (en) | Systems and methods for a dual oxygen center | |
EP2830702A4 (fr) | Système de neuromodulation et procédés associés | |
EP2843036A4 (fr) | Système de culture cellulaire et procédé de culture cellulaire | |
EP2860240A4 (fr) | Appareil pour culture cellulaire et procédé de culture cellulaire l'utilisant | |
HK1214412A1 (zh) | 電化學生物反應器模塊和使用所述模塊的方法 | |
EP2749075A4 (fr) | Procédés et appareil pour la sélection d'une cellule | |
EP2851986A4 (fr) | Pile à combustible et procédé de production de cette dernière | |
GB2507466B (en) | Fuel cell apparatus | |
PT2785683T (pt) | Moduladores de célula inkt e métodos para o seu uso | |
EP2911613A4 (fr) | Procédés et systèmes pour fixation de matériau | |
EP2824182A4 (fr) | Procédé pour la stimulation de lymphocytes t et son utilisation | |
EP2824742A4 (fr) | Système de pile à combustible et son procédé de commande | |
GB2509148B (en) | Method and apparatus for cell activation | |
EP2893964A4 (fr) | Dispositif de raffinage comprenant un réacteur continu et procédé de raffinage utilisant un réacteur continu | |
EP2660314A4 (fr) | CELLULES SPi ET LEUR PROCÉDÉ DE PRODUCTION | |
EP2905834A4 (fr) | Système de pile à combustible et procédé de commande | |
EP2940771A4 (fr) | Système de pile à combustible et procédé pour sa commande | |
PT2861713T (pt) | Método e sistema de cultura celular | |
SI2687281T1 (sl) | Sistem in metoda za absorbiranje posameznih komponent v plinih | |
HK1226099A1 (zh) | 用於腫瘤內引入細胞毒性t淋巴細胞和/或nkt細胞以及抗tnf和/或抗il-10的治療和方法 |